Victoria Weaver, DO
Internal Medicine · Overland Park, KSNPI 1497137566
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 438 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,598, 3.4 times the $466 reported in 2019. Among internal medicine clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 438 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$800
- Pfizer$794
- Lilly USA, LLC$726
- AstraZeneca$460
- Amgen$420
- plus $3K from 35 others
What the payments were for
- Food & beverage$7,197100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 79 | $1,375 |
| Novo Nordisk | 49 | $800 |
| Pfizer | 52 | $794 |
| Lilly USA, LLC | 39 | $726 |
| AstraZeneca | 27 | $460 |
| Amgen | 34 | $420 |
| GSK | 24 | $331 |
| Amarin Pharma, Inc. | 20 | $315 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $268 |
| Abbott | 9 | $172 |
| Novartis | 11 | $160 |
| Johnson & Johnson | 9 | $129 |
| Astellas Pharma US Inc | 8 | $128 |
| Akcea Therapeutics, Inc. | 1 | $118 |
| Boehringer Ingelheim | 6 | $97 |
| Sanofi-aventis U.S. LLC | 4 | $90 |
| Phathom Pharmaceuticals, Inc. | 4 | $87 |
| Eisai Inc. | 4 | $72 |
| Merck | 5 | $70 |
| Idorsia Pharmaceuticals US Inc | 3 | $66 |
| E.r. Squibb & Sons, L.L.C. | 4 | $60 |
| Esperion Therapeutics, Inc. | 4 | $58 |
| Corium, LLC | 2 | $41 |
| Gilead | 3 | $39 |
| Cequr Corporation | 1 | $38 |
| Boston Scientific | 2 | $33 |
| Ironwood Pharmaceuticals, Inc | 2 | $27 |
| Abiomed | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Electromed, Inc. | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Bayer | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEGSEDI$118
How this compares
$7,197 in reported general payments places this provider in the 95th percentile of 705 internal medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 129 | $157,811 |
| OzempicSemaglutide | 87 | $117,439 |
| EliquisApixaban | 90 | $89,131 |
| TrulicityDulaglutide | 34 | $45,309 |
| JardianceEmpagliflozin | 44 | $44,590 |
| XareltoRivaroxaban | 19 | $29,286 |
| LinzessLinaclotide | 17 | $19,660 |
| JanuviaSitagliptin Phosphate | 19 | $18,144 |
| MyrbetriqMirabegron | 11 | $14,055 |
| Repatha SureclickEvolocumab | 14 | $12,898 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 26 | $12,327 |
| SynthroidLevothyroxine Sodium | 105 | $12,252 |
| Ajovy SyringeFremanezumab-Vfrm | 11 | $8,563 |
| Rosuvastatin Calcium | 349 | $4,352 |
| Levothyroxine Sodium | 423 | $4,119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $726 | $203,120163 claims |
| Novo NordiskOzempic | $800 | $117,43987 claims |
| PfizerEliquis | $794 | $89,13190 claims |
| Boehringer IngelheimJardiance | $97 | $44,59044 claims |
| AbbVieLinzess, Synthroid | $1,375 | $31,911122 claims |
| Johnson & JohnsonXarelto | $129 | $29,28619 claims |
| MerckJanuvia | $70 | $18,14419 claims |
| Astellas Pharma US IncMyrbetriq | $128 | $14,05511 claims |
| GSKAnoro Ellipta | $331 | $12,32726 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $4,119423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 705 internal medicine providers in Kansas.
Other internal medicine in Overland Park
- Herbert WaxmanOverland Park$82K
- Shadrach SmithOverland Park$27K
- David EdalatiOverland Park$21K
- Jennifer BrownOverland Park$9K
- Ammar KhalifaOverland Park$8K
- Bruce SalvaggioOverland Park$8K
- Vijaya SamuelOverland Park$8K
- Shazia Walijan MunirOverland Park$7K
- Matthew SwanOverland Park$7K
- Michelle LesterOverland Park$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.